
About BioSyent
BioSyent is a publicly listed company based in Toronto (Canada) founded in 2003. BioSyent is focused on developing innovative medicines for Canadians. It operates on a Reseller / Distribution model. The company has 60 employees. BioSyent has completed 1 acquisition, including Oralscience. BioSyent offers products and services including Innovative Medicines. Its focus areas include Pharmaceuticals and Specialty Pharmaceuticals. Its legal entity is BioSyent Inc.
Company details
BioSyent is engaged in sourcing, licensing, acquiring, and developing innovative pharmaceutical and healthcare products to address unmet medical needs in Canada and select international markets. The company is committed to improving patient lives through unique and effective solutions across various therapeutic areas. Operations are supported by a dedicated all-Canadian team, emphasizing integrity, respect, and leadership in the specialty pharmaceutical sector.
- Headquarters Toronto, Canada
- Employees 60
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biosyent.com
- Social LinkedIn YouTube
- Legal Name Biosyent Inc.
- Annual Revenue$31.44 M (USD)22.9as on Dec 31, 2025
- Net Profit$6.58 M (USD)23.96as on Dec 31, 2025
- EBITDA$8.89 M (USD)31.89as on Dec 31, 2025
- Employee Count60
- Investments & Acquisitions
Products & Services of BioSyent
BioSyent offers a comprehensive portfolio of products and services, including Innovative Medicines.
Innovative medicines are developed for Canadian healthcare needs.
Apps and channels of BioSyent
its YouTube channel BioSyent Pharma has 115 subscribers and 30 videos.
Videos from BioSyent
The most watched videos on BioSyent's YouTube channel, BioSyent Pharma (115 subscribers). Click a video to play it here.
More on BioSyent Pharma.
People of BioSyent
12 people are tracked at BioSyent (7 in leadership, 5 in team); the tracked headcount is 60.
| Name | Role | Group |
|---|---|---|
Maulik Patel | Director Of Business Development | Leadership |
Joost Van Der Mark | Vice President, Corporate Development | Leadership |
Kevin Wilson | Vice President, Community Business Unit | Leadership |
Ramesh Moothan | Director, International Business Unit | Leadership |
Rene C Goehrum | Chairman/President/CEO | Leadership |
Robert J. March | Vice President & Chief Financial Officer | Leadership |
Ritu Kapoor | Director Of Finance | Leadership |
Mohamed Makram | Business Development Analyst | Team |
Jonathan Eccles | Accounting Analyst | Team |
Sara Colman | Senior Marketing Manager | Team |
Joe Holloway | Representative | Team |
Jennifer Truong | Business Intelligence Analyst | Team |
Complete people profiles for BioSyent
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of BioSyent
BioSyent is a publicly listed company on the TSXV with ticker symbol RX in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Jun 2006
- Listed onTSX-V: RX
- Listed entityBioSyent Inc.
- Exchange sectorHealth technology
- ISINCA0906901081
- Share price15.97 CAD (-6.88% on the day) · 2026-10-13
- Market capitalisation180,602,098.00 CAD
- Price to earnings18.6
- EPS (diluted, trailing year)0.86 CAD
- Dividend yield1.35%
- Volume (last session)27,732
Financials of BioSyent
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 43.0M CAD | 9.0M CAD | 12.2M CAD |
| 2024 | 35.0M CAD | 7.3M CAD | 9.2M CAD |
| 2023 | 31.6M CAD | 6.5M CAD | 8.0M CAD |
| 2022 | 27.9M CAD | 5.5M CAD | 7.4M CAD |
| 2021 | 28.6M CAD | 6.3M CAD | 8.7M CAD |
Detailed financial statements for BioSyent
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioSyent
BioSyent has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Oralscience.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Offers dental care products, oral hygiene tools, and educational resources for health. | oralscience.com | 0 | Feb 2026 | •••• |
Complete acquisition details for BioSyent
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BioSyent
3 dated milestones of BioSyent across 23 years, from founding to its latest funding, stage changes and deals.
- Founded BioSyent is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Oralscience.
Web traffic of BioSyent
The website of BioSyent (biosyent.com) receives about 4.3K visits a month.
- Monthly visits4.3K
▼ 3.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biosyent
Complete news archive for BioSyent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioSyent
BioSyent was founded in 2003.
BioSyent is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
BioSyent has 60 employees.
Annual revenue of BioSyent is $31.44M as on Dec 31, 2025.
BioSyent is engaged in sourcing, licensing, acquiring, and developing innovative pharmaceutical and healthcare products to address unmet medical needs in Canada and select international markets. The company is committed to improving patient lives through unique and effective solutions across various therapeutic areas. Operations are supported by a dedicated all-Canadian team, emphasizing integrity, respect, and leadership in the specialty pharmaceutical sector.
BioSyent offers Innovative Medicines.
Yes, BioSyent is publicly traded on TSXV under the ticker symbol RX.
BioSyent has made 1 acquisition, including Oralscience.
BioSyent operates through Biosyent Inc..
